Tradestie Institutional Equity Comparison Engine
BBLG vs CING โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CING Overall Edge
CING Captures Institutional Edge (2โ1 Pillars ยท 2โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cingulate Inc. Common Stock (CING) driven by superior Momentum & Technical, Options & Structure while BBLG counters with relative strength in Growth & Margin. Fundamentally, BBLG trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CING at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BBLG sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BBLG N/M vs CING N/M Fwd P/E
Growth & Margin Winner
BBLG
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
CING
1Y -81.9% vs +35.4% ยท 52W Pos 1% vs 18%
Options & Structure Winner
CING
BREAKDOWN (N/A IV) vs BREAKDOWN (16th %ile IV)
BBLG
NASDAQ
Bone Biologics Corp Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.29
-1.43% 1D
Market Cap
$1.1M
1M Return
-29.35%
1Y Return
-81.88%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 54.0
Flow 50.0
Mom 84.0
CING
NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.72
+26.0% 1D
Market Cap
$62.5M
1M Return
+8.37%
1Y Return
+35.39%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 31.0
Fund 50.0
Flow 67.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BBLG -81.88%
CING +35.39%
Spread: +117.27 pp (CING Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BBLG TTM Op. Margin: 0.0%
CING TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBLG vs CING. Trailing 12-month operating profitability (BBLG 0.0% vs CING 0.0%) and valuation multiples (BBLG N/M vs CING N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BBLG | CING | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1M | $62.5M | Larger Scale | CING |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -47.5% | -198.7% | Higher ROE | BBLG |
| 52-Week Range Position Momentum | 1% ($0โ$2) | 18% ($3โ$12) | Stronger Trend | CING |
| Beta / 30D Volatility Risk Regime | 0.99ฮฒ ยท 100% Vol | 1.07ฮฒ ยท 121% Vol | Lower Realized Risk | BBLG |
| Unified Institutional Score Composite Signal | 45.5 / 100 (HOLD) | 44.8 / 100 (HOLD) | Higher Composite | BBLG |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BBLG vs CING Buy Guide
BBLG
BREAKDOWN
104d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
CING
BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BBLG nor CING registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.